Literature DB >> 12628178

SET-ting the stage for life and death.

Debabrata Chakravarti1, Rui Hong.   

Abstract

Cytotoxic T lymphocytes release granzymes (Gzm) A and B to induce apoptosis or programmed cell death of virally infected or tumor cells. In this issue of Cell, Fan et al. identify the tumor metastasis suppressor NM23-H1 as a GzmA-activated, apoptosis-inducing DNase and the oncoprotein SET as its inhibitor. Work from the Lieberman and Wang groups indicates a surprising role for a group of acidic nucleo-cytoplasmic proteins in regulating apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628178     DOI: 10.1016/s0092-8674(03)00151-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  13 in total

1.  Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.

Authors:  Patrick T Reilly; Yun Yu; Ali Hamiche; Lishun Wang
Journal:  Bioessays       Date:  2014-08-25       Impact factor: 4.345

2.  RNA expression in a cartilaginous fish cell line reveals ancient 3' noncoding regions highly conserved in vertebrates.

Authors:  David Forest; Ryuhei Nishikawa; Hiroshi Kobayashi; Angela Parton; Christopher J Bayne; David W Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

3.  Inhibition of Ku70 acetylation by INHAT subunit SET/TAF-Iβ regulates Ku70-mediated DNA damage response.

Authors:  Kee-Beom Kim; Dong-Wook Kim; Jin Woo Park; Young-Joo Jeon; Daehwan Kim; Sangmyung Rhee; Jung-Il Chae; Sang-Beom Seo
Journal:  Cell Mol Life Sci       Date:  2013-12-05       Impact factor: 9.261

4.  A critical evaluation of biochemical activities reported for the nucleoside diphosphate kinase/Nm23/Awd family proteins: opportunities and missteps in understanding their biological functions.

Authors:  Patricia S Steeg; Massimo Zollo; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-25       Impact factor: 3.000

5.  De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins.

Authors:  Tiziana Squillaro; Valeria Severino; Nicola Alessio; Annarita Farina; Giovanni Di Bernardo; Marilena Cipollaro; Gianfranco Peluso; Angela Chambery; Umberto Galderisi
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Overexpression of the pp32r1 (ANP32C) oncogene or its functional mutant pp32r1Y140H confers enhanced resistance to FTY720 (Finguimod).

Authors:  Salma Buddaseth; Wiebke Göttmann; Rainer Blasczyk; Trevor Huyton
Journal:  Cancer Biol Ther       Date:  2013-12-12       Impact factor: 4.742

7.  Inhibition of p53 acetylation by INHAT subunit SET/TAF-Iβ represses p53 activity.

Authors:  Ji-Young Kim; Kyu-Sun Lee; Jin-Ee Seol; Kweon Yu; Debabrata Chakravarti; Sang-Beom Seo
Journal:  Nucleic Acids Res       Date:  2011-09-12       Impact factor: 16.971

8.  NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment.

Authors:  Yi-Fen Wang; Chun-Ju Chang; Jen-Hwey Chiu; Chin-Ping Lin; Wing-Yin Li; Shyue-Yih Chang; Pen-Yuan Chu; Shyh-Kuan Tai; Yu-Jen Chen
Journal:  Oncotarget       Date:  2014-09-15

9.  Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.

Authors:  Bharath Kumar Velmurugan; Kun-Tu Yeh; Chien-Hung Lee; Shu-Hui Lin; Mei-Chung Chin; Shang-Lun Chiang; Zhi-Hong Wang; Chun-Hung Hua; Ming-Hsui Tsai; Jan-Gowth Chang; Ying-Chin Ko
Journal:  Oncotarget       Date:  2016-03-08

10.  Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon.

Authors:  Rosalia Maglietta; Vania Cosma Liuzzi; Elisa Cattaneo; Endre Laczko; Ada Piepoli; Anna Panza; Massimo Carella; Orazio Palumbo; Teresa Staiano; Federico Buffoli; Angelo Andriulli; Giancarlo Marra; Nicola Ancona
Journal:  BMC Cancer       Date:  2012-12-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.